关于皮下特异性免疫治疗过敏性鼻炎的认识  

Subcutaneous specific immunotherapy for allergic rhinitis

作　　者：李继育 李南 宋红梅[2] Li Jiyu;Li Nan;Song Hongmei(Chengdu University of TCM,Chengdu,Sichuan,610075;Hospital of Chengdu University of TCM,Chengdu,Sichuan,610072)

机构地区：[1]成都中医药大学,四川成都610075 [2]成都中医药大学附属医院,四川成都610072

出　　处：《中医眼耳鼻喉杂志》2024年第1期48-50,54,共4页Journal of Chinese Ophthalmology and Otorhinolaryngology

基　　金：四川省科技厅重点研发项目(2023YFS0324);四川省中医药管理局课题(2023MS325);成都中医药大学临床医学院2022年教改重点项目(JYJX202206);成都中医药大学教育教学改革项目(JGJD202203)。

摘　　要：过敏性鼻炎(AR)是耳鼻喉科常见病。皮下注射免疫治疗对过敏性鼻炎时可以起到脱敏效果,改变过敏体质,临床应用广泛,本文对皮下免疫治疗过敏性鼻炎的认识进行综述,为治疗过敏性鼻炎提供更深刻的理论依据。Allergic rhinitis(AR)is a common disease in otolaryngology.In the treatment of allergic rhinitis,subcutaneous immunotherapy can play a role in desensitizing effect and changing allergic constitution,which is widely used in clinic.This article reviews the understanding of subcutaneous immunotherapy for allergic rhinitis,providing a more profound theoretical basis for clinical treatment of allergic rhinitis.

关 键 词：皮下特异性免疫疗法 过敏性鼻炎 过敏原 

分 类 号：R765[医药卫生—耳鼻咽喉科]